MEDIA ADVISORY: Opioids, MS, Clot-Dissolving Drugs, and Depression to be Focus of July 19 PCORI Meeting

PCORI Board Considers Funding for Opioids, MS, Clot-Dissolving Drugs, and Depression

Research proposals on the comparative effectiveness of long-term opioid use for chronic pain, the blood clot dissolving drugs, therapies for multiple sclerosis, and strategies for treatment-resistant depression are among the studies that will be considered for funding by the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors at its next meeting. The Board will vote on funding awards for these and other proposed studies when it meets on Tuesday, July 19.

When and Where: The meeting will run from noon to 2 p.m. ET Tuesday, July 19, via teleconference and webinar. Register here to listen.

Interviews: To schedule an interview with PCORI Executive Director Joe Selby, MD, MPH, or any of the researchers whose proposed studies are approved during the meeting, please contact Mary McNamara, PCORI’s Senior Media Relations Specialist: 202-370-9480 or mmcnamara@pcori.org.